April 2021 FDA Recall Drug by Edge Pharma, Llc
D-0335-2021 - Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility

This Class II drug recall was voluntarily initiated by Edge Pharma, Llc on April 12, 2021 for the product Drug. The FDA reported the reason for recall as defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0335-2021

Reason for Recall
Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility
Initiated
04-12-2021
Reported
04-28-2021
Quantity
5850 syringes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the US
Betadine (Povidone-Iodine) 5%, 0.5mL per syringe Single Use Syringe Rx only, For Topical Ophthalmic Use (DO NOT INJECT) STERILE OPHTHALMIC SOLUTION, PRESERVATIVE FREE, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178

Batch or Lot Expiration Information

Lot# Lot 02-2021-16@4 BUD 5/31/2021